Cite
HARVARD Citation
Mease, P. et al. (n.d.). FRI0451 SECUKINUMAB PROVIDES SUSTAINED IMPROVEMENTS IN THE SIGNS AND SYMPTOMS IN PSORIATIC ARTHRITIS: FINAL 5 YEAR EFFICACY AND SAFETY RESULTS FROM A PHASE 3 TRIAL. Annals of the rheumatic diseases. p. 917. [Online].